Association of AXIN2 s2240308 C>T, rs1133683 C>T, rs7224837 A>G Polymorphisms with Susceptibility to Breast Cancer

Background: The association of genetic polymorphisms at Axis inhibition protein 2 (AXIN2) gene and susceptibility to different cancer has attracted much interest. The present study aimed to evaluate the association between AXIN2 rs2240308 C>T, rs1133683 C>T, rs7224837 A>G polymorphisms with susceptibility to breast cancer. Methods: A polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay was designed to genotype the AXIN2 rs2240308 C>T, rs1133683 C>T, rs7224837 A>G polymorphisms among 150 breast cancer patients and 150 healthy subjects. Results: The frequencies of these genetic variants were in agreement with Hardy-Weinberg equilibrium in healthy controls (p>0.05). The frequencies of AXIN2 rs2240308 C>T, rs1133683 C>T, rs7224837 A>G genotypes were similar in breast cancer patients and controls. There was no a significant association between the AXIN2 SNP and risk of breast cancer. Conclusion: The impact of AXIN2 polymorphisms in the breast cancer development remains unclear. Our results indicated that AXIN2 rs2240308, rs7224837 and rs1133683 polymorphisms did not contribute to increased risk of breast cancer. More studies with larger sample sizes and diverse ethnicities are warranted to verify our finding.

[1]  Kylie L. Gorringe,et al.  Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study , 2021, NPJ breast cancer.

[2]  Zhiqing Liu,et al.  Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer. , 2021, Journal of medicinal chemistry.

[3]  Wei Wu,et al.  New insights of the correlation between AXIN2 polymorphism and cancer risk and susceptibility: evidence from 72 studies , 2021, BMC cancer.

[4]  K. Majidzadeh-A,et al.  Expression of SCUBE2 and BCL2 Predicts Favorable Response in ERα Positive Breast Cancer. , 2021, Archives of Iranian medicine.

[5]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[6]  Faying Xu,et al.  Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities , 2020, Molecular cancer.

[7]  F. Ghorbani,et al.  Associations of BCL2 CA-Repeat Polymorphism and Breast Cancer Susceptibility in Isfahan Province of Iran , 2020, Biochemical Genetics.

[8]  M. Brizzi,et al.  The Wnt Signalling Pathway: A Tailored Target in Cancer , 2020, International journal of molecular sciences.

[9]  H. Neamatzadeh,et al.  Cancer and Coronavirus Disease (COVID-19): Comorbidity, Mechanical Ventilation, and Death Risk , 2020, Journal of Gastrointestinal Cancer.

[10]  M. Guo,et al.  Glioblastoma stem cells and Wnt signaling pathway: molecular mechanisms and therapeutic targets , 2020, Chinese Neurosurgical Journal.

[11]  W. Schiemann,et al.  Epithelial–Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance , 2020, Molecular Cancer Research.

[12]  A. Seifalian,et al.  Key Regulatory miRNAs and their Interplay with Mechanosensing and Mechanotransduction Signaling Pathways in Breast Cancer Progression , 2020, Molecular Cancer Research.

[13]  Rodney Hull,et al.  Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options. , 2020, American journal of cancer research.

[14]  M. Rasaee,et al.  Performance of a template enhanced hybridization process in biological media for the detection of a breast cancer biomarker , 2020 .

[15]  A. Shajari,et al.  Association of REarranged during Transfection (RET) c.73 + 9277T > C and c.135G > a Polymorphisms with Susceptibility to Hirschsprung Disease: A Systematic Review and Meta-Analysis , 2020, Fetal and pediatric pathology.

[16]  M. Lookzadeh,et al.  Association of Axis Inhibition Protein 2 Polymorphisms with Non-Syndromic Cleft Lip with or without Cleft Palate in Iranian Children , 2020, Fetal and pediatric pathology.

[17]  Haiyan Gao,et al.  The Association Between AXIN2 Gene Polymorphisms and the Risk of Breast Cancer in Chinese Women. , 2019, Genetic testing and molecular biomarkers.

[18]  Xiaolan Zhang,et al.  MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis , 2019, Theranostics.

[19]  S. Kargar,et al.  Angiotensin Converting Enzyme Insertion/Deletion Polymorphism is Associated with Breast Cancer Risk: A Meta-Analysis , 2018, Asian Pacific journal of cancer prevention : APJCP.

[20]  Elnaz Sheikhpour,et al.  A Survey on the Role of Interleukin-10 in Breast Cancer: A Narrative. , 2018, Reports of biochemistry & molecular biology.

[21]  M. Terry,et al.  Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies? , 2018, Journal of global oncology.

[22]  Bo Liu,et al.  Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis , 2018, Genes & diseases.

[23]  J. Yang,et al.  New concept of the Axin2 rs2240308 polymorphism and cancer risk: an updated meta-analysis. , 2016, Neoplasma.

[24]  J. Balko,et al.  Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease , 2016, Nature Reviews Clinical Oncology.

[25]  K. Czene,et al.  The Heritability of Breast Cancer among Women in the Nordic Twin Study of Cancer , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[26]  E. Kamali,et al.  Association between the polymorphism of CA dinucleotide repeat in intron 1 of NFκB1 gene and risk of breast cancer , 2015 .

[27]  B. Zhu,et al.  Quantitative assessment of the association between AXIN2 rs2240308 polymorphism and cancer risk , 2015, Scientific Reports.

[28]  H. Neamatzadeh,et al.  BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review , 2015, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[29]  C. Takahashi,et al.  AXIN2 Polymorphisms, the β-Catenin Destruction Complex Expression Profile and Breast Cancer Susceptibility. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[30]  M. Sheikhha,et al.  BRCA1 and BRCA2 common mutations in iranian breast cancer patients: a meta analysis. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[31]  A. Chien,et al.  Wnt Signaling in Melanoma , 2014 .

[32]  J. Shaik,et al.  Association of Single Nucleotide Polymorphisms in Wnt Signaling Pathway Genes with Breast Cancer in Saudi Patients , 2013, PloS one.

[33]  M. Mazaheri,et al.  Tamoxifen resistance and CYP2D6 copy numbers in breast cancer patients. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[34]  K. Bystricky,et al.  Auraptene Is an Inhibitor of Cholesterol Esterification and a Modulator of Estrogen Receptors , 2010, Molecular Pharmacology.

[35]  M. Marazita,et al.  AXIS inhibition protein 2, orofacial clefts and a family history of cancer. , 2009, Journal of the American Dental Association.

[36]  David N. Rider,et al.  Association of Genetic Variation in Genes Implicated in the β-Catenin Destruction Complex with Risk of Breast Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[37]  M. Aoe,et al.  Single nucleotide polymorphism of the AXIN2 gene is preferentially associated with human lung cancer risk in a Japanese population. , 2006, International journal of molecular medicine.

[38]  S. Parlee,et al.  This Work Is Licensed under a Creative Commons Attribution-noncommercial 4.0 International License , 2022 .